At Genetek Lifesciences, we are taking a bold step forward in our mission to deliver world-class healthcare solutions. Our upcoming EU-compliant manufacturing facility at MIHAN, Nagpur represents a new era of growth, quality, and global integration. This state-of-the-art facility is being designed to meet the most stringent international regulatory standards, ensuring that every product manufactured aligns with European Union Good Manufacturing Practices (EU-GMP).

Genetek Lifesciences Pvt. Ltd. announced its participation in CPHI Frankfurt 2025, one of the world’s most prestigious pharmaceutical exhibitions. Scheduled for September, the event will bring together leading companies, innovators, and decision-makers from across the pharmaceutical industry. CPHI is widely recognized as the premier platform for global pharma networking, knowledge exchange, and business development. It serves as a convergence point

in-house Polypropylene Vials Manufacturing  Equipped with modern moulding technology and advanced quality systems, the line is designed to meet stringent regulatory standards for manufacture of Plastic vials. Beyond in-house needs, the company aims to serve wider industry requirements, reinforcing its role as a reliable partner in healthcare solutions. Details: – Genetek Lifesciences Pvt. Ltd. has announced the start of plastic vial

In a significant breakthrough in India’s fight against Mucormycosis, commonly known as black fungus, Wardha-based Genetek Lifesciences Pvt. Ltd. successfully manufactured and rolled out its first batch of Amphotericin-B Emulsion injections. Amphotericin-B, regarded as a frontline antifungal therapy, was described by medical professionals as a vital drug in controlling the aggressive infection that had emerged in COVID-19 patients during the

In a significant step to address India’s surging demand for COVID-19 medicines, Wardha-based Genetek Lifesciences Pvt. Ltd. was authorized to manufacture the antiviral drug Remdesivir, considered a critical treatment for severe coronavirus cases. The authorization came at a time when hospitals across the country faced an unprecedented shortage of the injection. Production at Genetek Lifesciences Wardha facility began immediately under

At Genetek Lifesciences, we are proud to announce two major developments that strengthen our position as a trusted partner in healthcare innovation. On one front, we are introducing sterile formulations tailored for clinical trials, ensuring safety, precision, and international compliance to accelerate the development of novel therapies. These formulations are designed to support pharmaceutical companies and research institutions in advancing treatments